The UK pharmaceutical sector and laboratory sector will enter 2026 in a steadier position than in recent years. While the pace of new project emergence has slowed compared with the COVID period, the market remains active, albeit different, with significant opportunities for suppliers of capital equipment, services and expertise. Suppliers can engage with the wide Continue reading